Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Haywood sittng at $0.40. Don't think it will be filled.

<< Previous

Bullboard Posts

Next >>

Comment by wizzdumbon Apr 06, 2023 1:08pm

110 Views

Post# 35383377

RE:Haywood sittng at $0.40. Don't think it will be filled.

Yeah Cameron addressed this previously - there are very specific rules and they cannot be seen as influencing the price as part of the buyback. A lot of the weak hands have been removed over the last few months. The asks are holding much more firmly.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?